Loading clinical trials...
Loading clinical trials...
A randomized, open label, single-dose, 6-sequence, 3-period, crossover study to evaluate a pharmacokinetic drug interaction between eperisone hydrochloride and aceclofenac in healthy male subjects.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Hanmi Pharmaceutical Company Limited
NCT07176845 · Acute Low Back Pain, Chronic Low Back Pain (CLBP)
NCT07118033 · Sub Acute Low Back Pain With Radiating Symptoms
NCT05001555 · Acute Low Back Pain
NCT04968158 · Acute Low Back Pain
NCT03502187 · Subacute Low Back Pain
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions